Amaris first to offer two energy levels

Article

Amaris is the first refractive laser in the world to offer two separate energy levels for optimal corneal smoothing, according to an announcement from Schwind, the laser's manufacturer.

Amaris is the first refractive laser in the world to offer two separate energy levels for optimal corneal smoothing, according to an announcement made by Schwind, the laser's manufacturer.

The laser, which has a 500 Hz pulse frequency, includes a unique "Automatic Fluence Level Adjustment" feature, enabling the laser to switch between high and low levels of fluence to provide the most appropriate energy level for each cornea. Approximately 80% of the ablation is performed at high fluence; for the remaining 20% of the procedure, the laser automatically lowers the fluence value to whatever level is most appropriate. Dual fluence levels are also able to treat subjective refractions and higher order aberrations.

Schwind believes that this combination of high and low fluence values and pulse frequencies offers optimum results for patients, as well as increasing the lifetime of the equipment.

The images show ablation variations: please click on an image to enlarge.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.